Werlinich Asset Management, LLC NVO Holdings History
Werlinich Asset Management, LLC's Novo Nordisk AS Holding Summary
As of 2025-06-30, Werlinich Asset Management, LLC held - shares of Novo Nordisk AS(NVO), totaling N/A. This investment constitutes 0% of their stock portfolio, and Werlinich Asset Management, LLC now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.
The initial trade took place in 2024Q4. And since then Werlinich Asset Management, LLC has made 2 purchases of NVO, at an average price of $107.85, for a total of 12,370.00 shares. In addition, there have been 1 sales at an average price of $68.04 for 12,370.00 shares. Based on historical transaction data and NVO's current price of $69.58, Werlinich Asset Management, LLC's estimated gain on his NVO holdings is $-492,407.45, reflecting a -36.91% gain to date.
Werlinich Asset Management, LLC NVO ($69.58) Holding Chart
Werlinich Asset Management, LLC NVO ($69.58) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
